Open Access<p>Sustained Corticosteroid-Free Clinical Remission During Vedolizumab Maintenance Therapy in Patients with Ulcerative Colitis on Stable Concomitant Corticosteroids During Induction Therapy: A Post Hoc Analysis of GEMINI 1</p>
Author(s) -
Edward V. Loftus,
Bruce E. Sands,
Jean–Frédéric Colombel,
Iris Dotan,
Javaria Mona Khalid,
David Tudor,
Parnia Geransar
Publication year - 2020
Publication title -
clinical and experimental gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.113
H-Index - 30
ISSN - 1178-7023
DOI - 10.2147/ceg.s248597
Subject(s) - vedolizumab , medicine , ulcerative colitis , placebo , maintenance therapy , clinical endpoint , corticosteroid , post hoc analysis , adverse effect , odds ratio , concomitant , gastroenterology , intention to treat analysis , surgery , clinical trial , chemotherapy , disease , alternative medicine , pathology
Corticosteroid-free clinical remission is important in ulcerative colitis.